Important resolutions of the Company's 2022 Annual Shareholders' Meeting
· Issued by Pharmaengine, Inc.
Close
Today's Information
Provided by: PharmaEngine, Inc.
SEQ_NO
6
Date of announcement
2022/05/27
Time of announcement
18:29:41
Subject
Important resolutions of the Company's 2022
Annual Shareholders' Meeting
Date of events
2022/05/27
To which item it meets
paragraph 18
Statement
1.Date of the shareholders' meeting:2022/05/27
2.Important resolutions I.Profit distribution/deficit compensation:
Acknowledgment of the proposal for distribution of 2021 net profits
3.Important resolutions II.Amendments of the company charter:
Acceptance of the amendments to the Company's "Articles of Incorporation"
4.Important resolutions III.Business report and financial statements:
Acknowledgment of the 2021 Business Report and Financial Statements
5.Important resolutions IV.Election for directors and supervisors:
To elect new 9 Directors (including 3 Independent Directors). The list of
Directors elected:
Independent Directors: Chien-Huang Lin, Ming-Daw Chang, Chih-Li Wang
Directors: Ming-Feng Hou
Directors:
Legal Representative of TTY Biopharm Co., Ltd.: Ted Tu, Wen-Hung Hsu,
Rui-Wen Wu
Legal Representative of National Development Fund, Executive Yuan:
Ming-Shiang Wu, Yi-Hui Lin
6.Important resolutions V.Other matters:
Acceptance of the proposal for releasing the prohibition on Directors or
their representatives from participation in competitive business
7.Any other matters that need to be specified:
(1) Acceptance of the amendments to the Company's "Operational Procedures
of Loaning Funds to Others"
(2) Acceptance of the amendments to the Company's " Operational Procedures
for Acquisition & Disposal of Asset"
(3) Acceptance of the amendments to the Company's "Procedures for Election
of Directors"
(4) Acceptance of the issuance of restricted stock awards
